- Home
- GOOGL vs LLY Comparison
GOOGL vs LLY Comparison
Compare GOOGL & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOOGL | LLY |
|---|---|---|
| Founded | 1998 | 1876 |
| Country | United States | United States |
| Employees | 194668 | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4T | 1.0T |
| IPO Year | 2015 | 2007 |
Fundamental Metrics
Financial Performance| Metric | GOOGL | LLY |
|---|---|---|
| Price | $366.67 | $1,099.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 44 | 19 |
| Target Price | $358.75 | ★ $1,218.84 |
| AVG Volume (30 Days) | ★ 24.0M | 2.4M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | 0.24% | ★ 0.81% |
| EPS Growth | 34.45 | ★ 95.99 |
| EPS | ★ 10.81 | 8.26 |
| Revenue | ★ $402,836,000,000.00 | $65,179,000,000.00 |
| Revenue This Year | $20.79 | $27.15 |
| Revenue Next Year | $15.27 | $16.04 |
| P/E Ratio | ★ $33.72 | $134.62 |
| Revenue Growth | 15.09 | ★ 44.70 |
| 52 Week Low | $162.07 | $623.78 |
| 52 Week High | $408.61 | $1,182.73 |
Technical Indicators
Market Signals| Indicator | GOOGL | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 48.39 | 53.97 |
| Support Level | $298.56 | $1,032.70 |
| Resistance Level | $408.61 | $1,108.78 |
| Average True Range (ATR) | 10.28 | 33.73 |
| MACD | -1.17 | -7.10 |
| Stochastic Oscillator | 64.53 | 35.68 |
Price Performance
Historical ComparisonAbout GOOGL Alphabet Inc.
Alphabet is a holding company that wholly owns internet giant Google. The California-based company derives slightly less than 90% of its revenue from Google services, the vast majority of which is advertising sales. Alongside online ads, Google services houses sales stemming from Google's subscription services (YouTube TV and YouTube Music, among others), platforms (sales and in-app purchases on Play Store), and devices (Chromebooks, Pixel smartphones, and smart home products such as Chromecast). Google's cloud computing platform accounts for roughly 10% of Alphabet's revenue. The firm's investments in up-and-coming technologies such as self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.